125 related articles for article (PubMed ID: 10512164)
21. Immunosuppressive mechanisms in pure red cell aplasia--a review.
Nidorf D; Saleem A
Ann Clin Lab Sci; 1990; 20(3):214-9. PubMed ID: 2111653
[TBL] [Abstract][Full Text] [Related]
22. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
[TBL] [Abstract][Full Text] [Related]
23. [A case of pure red cell aplasia accompanied with granular lymphocytic leukemia the tumor cells of which suppressed colony formation of BFU-E, and which was successfully treated by cyclophosphamide and cyclosporin A].
Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
Rinsho Ketsueki; 1997 Nov; 38(11):1206-11. PubMed ID: 9423339
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin-A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia.
Chikkappa G; Pasquale D; Phillips PG; Mangan KF; Tsan MF
Am J Hematol; 1987 Oct; 26(2):179-89. PubMed ID: 3116843
[TBL] [Abstract][Full Text] [Related]
25. CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.
Xu Q; Yu J; Lin X; Li Y; Zhang K
Medicine (Baltimore); 2021 Nov; 100(47):e27874. PubMed ID: 34964755
[TBL] [Abstract][Full Text] [Related]
26. Pure red-cell aplasia requiring cytotoxic chemotherapy: presence of clonal T-lymphocytes without characteristics of chronic lymphocytic leukemia.
Nezu M; Kawano E; Ishii H; Nishimura M; Hirasawa A; Hashimoto S; Morio S; Aotsuka N; Nakamura H; Asai T; Saito Y; Oh H
Am J Hematol; 1996 Oct; 53(2):145-7. PubMed ID: 8892747
[No Abstract] [Full Text] [Related]
27. Treatment of pure red cell aplasia with ciclosporin: suppression of activated T suppressor/cytotoxic and NK-like cells in marrow and blood correlates with haematological response.
Tötterman TH; Bengtsson M
Eur J Haematol; 1988 Sep; 41(3):204-11. PubMed ID: 3141208
[TBL] [Abstract][Full Text] [Related]
28. [Progress in the clinical management of pure red cell aplasia and future prospects].
Hirokawa M
Rinsho Ketsueki; 2016 Feb; 57(2):110-6. PubMed ID: 26935627
[TBL] [Abstract][Full Text] [Related]
29. T-cell clonal disorder in acquired primary pure red cell aplasia.
Bai LY; Liu JH; Kau JP
Ann Hematol; 2004 Aug; 83(8):544-6. PubMed ID: 15141323
[No Abstract] [Full Text] [Related]
30. [Chronic T-cell lymphoproliferative disorder associated with pure red cell aplasia].
Chubachi A; Yoshida K; Endo Y; Miura A; Akihama T; Kuwayama A
Rinsho Ketsueki; 1989 Jan; 30(1):105-10. PubMed ID: 2497262
[TBL] [Abstract][Full Text] [Related]
31. [Pure red cell aplasia, associated with chronic lymphoid leukemia, successfully treated with closorine].
Rácz K; Telek B; Ujj G; Kiss A; Rák K; Udvardy M
Orv Hetil; 1997 Nov; 138(45):2883-7. PubMed ID: 9432638
[TBL] [Abstract][Full Text] [Related]
32. Evidence for reduced erythroid burst (BFUE) promoting function of T lymphocytes in the pure red cell aplasia of chronic lymphocytic leukemia.
Mangan KF; Chikkappa G; Scharfman WB; Desforges JF
Exp Hematol; 1981 May; 9(5):489-98. PubMed ID: 6972322
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
[TBL] [Abstract][Full Text] [Related]
34. T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
Kawakami F; Kawakami T; Yamane T; Maruyama M; Kobayashi J; Nishina S; Sakai H; Higuchi Y; Hamanaka K; Hirokawa M; Nakao S; Nakazawa H; Ishida F
Int J Hematol; 2022 Jun; 115(6):816-825. PubMed ID: 35275353
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and pathophysiological features of acquired pure red cell aplasia: based on the concept of T-cell dysregulations].
Ishida F
Rinsho Ketsueki; 2022; 63(8):893-898. PubMed ID: 36058860
[TBL] [Abstract][Full Text] [Related]
36. CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia.
Michishita Y; Hirokawa M; Fujishima N; Abe Y; Fujishima M; Guo YM; Ubukawa K; Liu J; Yoshioka T; Kameoka Y; Saitoh H; Tagawa H; Takahashi N; Sawada K
Immunol Lett; 2013 Feb; 150(1-2):23-9. PubMed ID: 23274961
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia.
Chikkappa G; Pasquale D; Zarrabi MH; Weiler RJ; Divakara M; Tsan MF
Am J Hematol; 1992 Sep; 41(1):5-12. PubMed ID: 1503099
[TBL] [Abstract][Full Text] [Related]
38. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Hirokawa M; Sawada K; Fujishima N; Kawano F; Kimura A; Watanabe T; Arai A; Matsui T; Nakao S; Urabe A; Omine M; Ozawa K
Am J Hematol; 2009 Mar; 84(3):144-8. PubMed ID: 19195037
[TBL] [Abstract][Full Text] [Related]
39. Clonal T cells of pure red-cell aplasia.
Masuda M; Teramura M; Matsuda A; Bessho M; Shimamoto T; Ohyashiki K; Omine M; Motoji T; Mizoguchi H
Am J Hematol; 2005 Aug; 79(4):332-3. PubMed ID: 16044445
[TBL] [Abstract][Full Text] [Related]
40. [Pure red-cell aplasia accompanied by neutropenia with increased granular lymphocytes--different effects of prednisolone and cyclophosphamide on improving anemia and neutropenia].
Hirasawa A; Wakabayashi Y; Sato T; Nishikawa T; Chiba S
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):98-103. PubMed ID: 7553045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
